Breast cancer: Tracking ctDNA to evaluate relapse risk
- PMID: 26370605
- DOI: 10.1038/nrclinonc.2015.159
Breast cancer: Tracking ctDNA to evaluate relapse risk
Comment on
-
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer.Sci Transl Med. 2015 Aug 26;7(302):302ra133. doi: 10.1126/scitranslmed.aab0021. Sci Transl Med. 2015. PMID: 26311728
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
